Genetic and Epigenetic Alterations in the MAP Kinase and PI3K/Akt Pathways in Thyroid Cancer

2016 ◽  
pp. 45-56
2016 ◽  
Vol 23 (7) ◽  
pp. 2302-2309 ◽  
Author(s):  
Michael G. White ◽  
Sapna Nagar ◽  
Briseis Aschebrook-Kilfoy ◽  
Farzana Jasmine ◽  
Muhammad G. Kibriya ◽  
...  

Oncotarget ◽  
2017 ◽  
Vol 8 (61) ◽  
pp. 103014-103031 ◽  
Author(s):  
Katie M. Mishall ◽  
Thomas C. Beadnell ◽  
Brent M. Kuenzi ◽  
Dorothy M. Klimczak ◽  
Giulio Superti-Furga ◽  
...  

2002 ◽  
Vol 87 (5) ◽  
pp. 2399-2399 ◽  
Author(s):  
Matthew D. Ringel ◽  
Elena Hardy ◽  
Victor J. Bernet ◽  
Henry B. Burch ◽  
Frank Schuppert ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-11 ◽  
Author(s):  
Rafael Martins de Morais ◽  
Alaor Barra Sobrinho ◽  
Calliandra Maria de Souza Silva ◽  
Jamila Reis de Oliveira ◽  
Izabel Cristina Rodrigues da Silva ◽  
...  

Papillary thyroid cancer (PTC) is the most common thyroid malignancy. Genetic and epigenetic alterations play a decisive role in the onset of several human neoplasms. Mutations and polymorphisms are two frequent genetic alterations. Located on chromosome 19 (19p13.11), the NIS SLC5A5 (solute carrier family 5 member 5) gene encodes a highly specialized and efficient 80–90 kDa transmembrane glycoprotein that mediates active transport of iodide from the bloodstream into the follicular cells. Given the highly significant role of NIS in the physiology and the cancer pathogenesis process, this paper’s objective is to provide a comprehensive assessment of the associations between NIS gene and protein with papillary thyroid cancer.


2014 ◽  
Vol 186 (2) ◽  
pp. 560
Author(s):  
K. Tsumagari ◽  
D. Slakey ◽  
D. Mondal ◽  
A. Abdel-Mageed ◽  
E. Kandil

Sign in / Sign up

Export Citation Format

Share Document